News & Updates
Filter by Specialty:
FLT3 inhibitor improves survival in patients with FLT3+ acute myeloid leukaemia
Patients diagnosed with acute myeloid leukaemia with an FLT3 mutation (FLT3+ AML) may benefit from the addition of an FLT3 inhibitor to intensive chemotherapy postinduction by improving event-free (EFS) or overall survival (OS), suggests a study.
FLT3 inhibitor improves survival in patients with FLT3+ acute myeloid leukaemia
23 Aug 2022
Live birth after breast cancer may improve overall survival
Women who become pregnant and have a live birth following a diagnosis of breast cancer may have better overall survival (OS) outcomes than those without live births post-cancer, according to a study presented at ESHRE 2022.
Live birth after breast cancer may improve overall survival
22 Aug 2022
Rise in late-stage cervical cancer in SG linked to suboptimal screening uptake
Local researchers note a rising trend of late-stage cervical cancer in Singapore, a pattern that they say is likely to be an effect of a less than optimal uptake of screening for the disease.
Rise in late-stage cervical cancer in SG linked to suboptimal screening uptake
22 Aug 2022
Patient decision aid helps in decision-making process when selecting regimen for CRC
A newly developed patient decision aid (PDA) aids in the shared decision-making in choosing first-line targeted therapy for metastatic colorectal cancer (CRC), reports a study in Taiwan.
